TARDBP and amyotrophic lateral sclerosis: Another breakthrough in the same year was that TDP-43 was identified as a major component of sporadic and familial cases of frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau-negative inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS) (53).